{"id":8434,"date":"2024-05-20T17:15:32","date_gmt":"2024-05-20T09:15:32","guid":{"rendered":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434"},"modified":"2024-05-20T17:20:50","modified_gmt":"2024-05-20T09:20:50","slug":"video-cerebraca-wafer-for-the-treatment-of-recurrent-malignant-brain-tumors-resistant-to-standard-therapy-hualien-tzu-chi-hospital","status":"publish","type":"page","link":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434","title":{"rendered":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"8434\" class=\"elementor elementor-8434\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-51f5b927 elementor-section-full_width elementor-section-stretched elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"51f5b927\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;,&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123016cd\" data-id=\"123016cd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d19a1d9 elementor-widget elementor-widget-html\" data-id=\"d19a1d9\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }<\/style><div class='embed-container'><iframe width='560' height='315' src='https:\/\/www.youtube-nocookie.com\/embed\/vcl8Iasd3K0?cc_load_policy=1&cc_lang_pref=en&rel=0' frameborder='0' allow='accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture' allowfullscreen><\/iframe><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6c5c3c0e elementor-widget elementor-widget-spacer\" data-id=\"6c5c3c0e\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.11.5 - 14-03-2023 *\/\n.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}.e-con{--container-widget-width:100%}.e-con-inner>.elementor-widget-spacer,.e-con>.elementor-widget-spacer{width:var(--container-widget-width,var(--spacer-size));--align-self:var(--container-widget-align-self,initial);--flex-shrink:0}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container,.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer,.e-con>.elementor-widget-spacer>.elementor-widget-container,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer{height:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner{height:var(--container-widget-height,var(--spacer-size))}<\/style>\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-181c798b elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"181c798b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.11.5 - 14-03-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#818a91;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#818a91;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><span style=\"color: #0d344a;\">Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, <a href=\"https:\/\/www.efbiotech.com\/wordpress\/?page_id=1778\">Cerebraca\u00ae Wafer<\/a>, for the <a href=\"https:\/\/www.efbiotech.com\/wordpress\/?page_id=1778\">treatment of malignant brain tumors<\/a>, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Hualien Tzu Chi Hosp<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"yandex-verification\" content=\"e40d2b34525f51ae\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"zh_TW\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Everfront Biotech - Rising Star in Pharmaceutical Innovation\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech\" \/>\n\t\t<meta property=\"og:description\" content=\"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-05-20T09:15:32+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-05-20T09:20:50+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress#listItem\",\"position\":1,\"name\":\"\\u4e3b\\u9801\",\"item\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434#listItem\",\"name\":\"[Video] Cerebraca\\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434#listItem\",\"position\":2,\"name\":\"[Video] Cerebraca\\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress#listItem\",\"name\":\"\\u4e3b\\u9801\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/#organization\",\"name\":\"Everfront Biotech Holding Company Limited\",\"description\":\"Rising Star in Pharmaceutical Innovation\",\"url\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/\",\"email\":\"efbiotech@efbiotech.com\",\"telephone\":\"+886227563796\",\"foundingDate\":\"2010-12-09\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/EFBHC-logo-6x6-1.png\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434\\\/#organizationLogo\",\"width\":709,\"height\":709,\"caption\":\"Everfront Biotech Holding Company Limited Logo\"},\"image\":{\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCQxUnnglfFi-xmHdahGZ9gQ\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434#webpage\",\"url\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434\",\"name\":\"[Video] Cerebraca\\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech\",\"description\":\"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.\",\"inLanguage\":\"zh-TW\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/?page_id=8434#breadcrumblist\"},\"datePublished\":\"2024-05-20T17:15:32+08:00\",\"dateModified\":\"2024-05-20T17:20:50+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/\",\"name\":\"Everfront Biotech\",\"alternateName\":\"EFBHC\",\"description\":\"Rising Star in Pharmaceutical Innovation\",\"inLanguage\":\"zh-TW\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.efbiotech.com\\\/wordpress\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech","description":"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.","canonical_url":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434","robots":"max-image-preview:large","keywords":"","webmasterTools":{"yandex-verification":"e40d2b34525f51ae","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.efbiotech.com\/wordpress#listItem","position":1,"name":"\u4e3b\u9801","item":"https:\/\/www.efbiotech.com\/wordpress","nextItem":{"@type":"ListItem","@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434#listItem","name":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)"}},{"@type":"ListItem","@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434#listItem","position":2,"name":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)","previousItem":{"@type":"ListItem","@id":"https:\/\/www.efbiotech.com\/wordpress#listItem","name":"\u4e3b\u9801"}}]},{"@type":"Organization","@id":"https:\/\/www.efbiotech.com\/wordpress\/#organization","name":"Everfront Biotech Holding Company Limited","description":"Rising Star in Pharmaceutical Innovation","url":"https:\/\/www.efbiotech.com\/wordpress\/","email":"efbiotech@efbiotech.com","telephone":"+886227563796","foundingDate":"2010-12-09","logo":{"@type":"ImageObject","url":"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png","@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434\/#organizationLogo","width":709,"height":709,"caption":"Everfront Biotech Holding Company Limited Logo"},"image":{"@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434\/#organizationLogo"},"sameAs":["https:\/\/www.youtube.com\/channel\/UCQxUnnglfFi-xmHdahGZ9gQ"]},{"@type":"WebPage","@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434#webpage","url":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434","name":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech","description":"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.","inLanguage":"zh-TW","isPartOf":{"@id":"https:\/\/www.efbiotech.com\/wordpress\/#website"},"breadcrumb":{"@id":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434#breadcrumblist"},"datePublished":"2024-05-20T17:15:32+08:00","dateModified":"2024-05-20T17:20:50+08:00"},{"@type":"WebSite","@id":"https:\/\/www.efbiotech.com\/wordpress\/#website","url":"https:\/\/www.efbiotech.com\/wordpress\/","name":"Everfront Biotech","alternateName":"EFBHC","description":"Rising Star in Pharmaceutical Innovation","inLanguage":"zh-TW","publisher":{"@id":"https:\/\/www.efbiotech.com\/wordpress\/#organization"}}]},"og:locale":"zh_TW","og:site_name":"Everfront Biotech - Rising Star in Pharmaceutical Innovation","og:type":"article","og:title":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech","og:description":"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.","og:url":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434","og:image":"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png","og:image:secure_url":"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png","article:published_time":"2024-05-20T09:15:32+00:00","article:modified_time":"2024-05-20T09:20:50+00:00","twitter:card":"summary_large_image","twitter:title":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS) - Everfront Biotech","twitter:description":"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.","twitter:image":"https:\/\/www.efbiotech.com\/wordpress\/wp-content\/uploads\/2023\/03\/EFBHC-logo-6x6-1.png"},"aioseo_meta_data":{"post_id":"8434","title":null,"description":"Hualien Tzu Chi Hospital collaborated with the neurosurgery team from Tri-Service General Hospital to conduct clinical trials for the development of a new drug, Cerebraca\u00ae Wafer, for the treatment of malignant brain tumors, under the leadership of the Superintendent, Dr. Shinn-Zon. Dr. Lin was invited by the President of the Asian Congress of Neurological Surgeons, Professor Yoko Kato, to share the results of the phase I clinical trial via video conference on June 8th at 8:30 PM.","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2024-05-20 09:15:44","updated":"2024-05-20 09:20:51","ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.efbiotech.com\/wordpress\" title=\"\u4e3b\u9801\">\u4e3b\u9801<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u4e3b\u9801","link":"https:\/\/www.efbiotech.com\/wordpress"},{"label":"[Video] Cerebraca\u00ae Wafer has achieved significant progress in Phase I clinical trials for the treatment of malignant brain tumors, and has been invited to speak at the Asian Congress of Neurological Surgeons (ACNS)","link":"https:\/\/www.efbiotech.com\/wordpress\/?page_id=8434"}],"_links":{"self":[{"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/pages\/8434"}],"collection":[{"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8434"}],"version-history":[{"count":5,"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/pages\/8434\/revisions"}],"predecessor-version":[{"id":8444,"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=\/wp\/v2\/pages\/8434\/revisions\/8444"}],"wp:attachment":[{"href":"https:\/\/www.efbiotech.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}